A 76-year-old man on cancer immunotherapy developed a mixed Mycobacterium tuberculosis and Aspergillus fumigatus empyema with pneumothorax, exposing key diagnostic and therapeutic gaps.

The advent of single-cell omics technologies has revolutionized our understanding of the complex cellular landscape in cancer. Traditional bulk sequencing ...

Dr. Efthimiou is treating patients with disc herniations, neuropathy, spinal stenosis and knee conditions at Ohio Pain & Rehabilitation.

Using red light therapy for weight loss is a growing trend. Discover the best RLT devices based on your needs in this simple guide.

If larger trials succeed, personalized mRNA vaccines could finally turn pancreatic cancer from a near-certain killer into a ...

Magnus Kalins likes golf. The eighth-grader from Ventura whose heart stopped beating when he was 3 plays every Wednesday with ...

A key protein, HOXD13, helps melanoma tumors grow and evade the immune system by boosting blood supply and blocking cancer-fighting T cells. Disabling it shrinks tumors and reopens the door for the ...

Sixth paragraph, fifth sentence of release issued April 20, 2026 at 10 p.m. PT/April 21, 2026 at 1 a.m. ET, should read: In addition, treatment with Gazyva plus standard therapy, versus placebo plus ...

Kelonia is developing a next-gen blood cancer treatment that’ll reprogram T-cells to help patients’ immune systems fight ...

Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today that the US Food and Drug Administration (FDA) has accepted the company’s supplemental Biologics License ...

CAR, was shown to be safe, with increasing efficacy corresponding to higher doses of the investigational treatment in nine patients with advanced ovarian cancer, mesothelioma or cholangiocarcinoma ...

A single infusion of ciltacabtagene autoleucel (Carvykti) led to a 100% minimal residual disease (MRD)-negativity rate in ...